A phase I study of tasisulam sodium (LY573636 sodium), a novel anticancer compound in patients with refractory solid tumors (Q35549459)

From Wikidata
Jump to navigation Jump to search
scientific article published on 23 March 2011
edit
Language Label Description Also known as
English
A phase I study of tasisulam sodium (LY573636 sodium), a novel anticancer compound in patients with refractory solid tumors
scientific article published on 23 March 2011

    Statements

    A phase I study of tasisulam sodium (LY573636 sodium), a novel anticancer compound in patients with refractory solid tumors (English)
    Christopher A Slapak

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit